Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care

Bulletin of the NYU Hospital for Joint Diseases

Volumn 70, Issue SUPPL. 1, 2012, Pages

  Pincus, Theodore ^a   Yazici, Yusuf ^a   Castrejón, Isabel ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERTOLIZUMAB PEGOL; PLACEBO;

ARTICLE; CLINICAL TRIAL (TOPIC); CROHN DISEASE ACTIVITY INDEX; DAS28; DOCTOR PATIENT RELATION; EXERCISE; FATIGUE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; MEDICAL HISTORY; MEDICAL INFORMATION; MORNING STIFFNESS; MULTIDIMENSIONAL HEALTH ASSESSMENT QUESTIONNAIRE; PATIENT ASSESSMENT; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; ROUTINE ASSESSMENT OF PATIENT INDEX DATA; VISUAL ANALOG SCALE;

ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; HUMANS; QUESTIONNAIRES; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 84872788840     PISSN: 19369719     EISSN: 19369727     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Weed LL. Medical records that guide and teach. N Engl J Med. 1968;278:593-600, 652-57.
2. Hampton JR, Harrison MJG, Mitchell JRA, et al. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J. 1975 May 31;2(5969):486-489.
3. Sandler G. The importance of the history in the medical clinic and the cost of unnecessary tests. Am Heart J. 1980 Dec;100(6 Pt 1):928-931.
4. Peterson MC, Holbrook JH, Hales DV, et al. Contributions of the history, physical examination, and laboratory investigation in marking medical diagnoses. West J Med. 1992 Feb;156(2):163-165.
5. Pryor DB, Shaw L, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med. 1993 Jan 15;118(2):81-90.
6. Castrejón I, McCollum L, Durusu Tanriover M, Pincus T. Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: Results of a physician survey. Arthritis Care Res (Hoboken). 2012 Aug;64(8):1250-1255.
7. Pincus T, Yazici Y, Sokka T. Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure. Rheum Dis Clin North Am. 2009 Nov;35(4):687-697,v.
8. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum.1993 Jun;36(6):729-740.
9. van Riel PLCM. Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis (Editorial). Br J Rheumatol. 1992 Dec;31(12):793-4.
10. Prevoo MLL, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995 Jan;38(1):44-8.
11. Aletaha D, Smolen J. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S100-S108.
12. Pincus T, Swearingen C, Wolfe F. Toward a multidimensional health assessment questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient friendly health assessment questionnaire format. Arthritis Rheum. 1999 Oct;42(10):2220-2230.
13. Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a multidimensional health assessment questionnaire for standard care of patients with rheumatic diseases. J Rheumatol. 2005 Aug;32(8):1432-1439.
14. Pincus T, Bergman MJ, Yazici Y, et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford). 2008 Mar;47(3):345-349.
15. Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: Proposed severity categories compared to DAS and CDAI categories. J Rheumatol. 2008 Nov;35(11):2136-2147.
16. Stucki G, Liang MH, Stucki S, et al. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Arthritis Rheum. 1995 Jun;38(6):795-798.
17. Pincus T, Yazici Y, Sokka T. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol. 2007 Aug;21(4):601-628.
18. Strand V, Cohen S, Crawford B, et al. Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology. 2004 Aug;43(4):640-7.
19. Cohen SB, Strand V, Aguilar D, Ofman JJ. Patientversus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology (Oxford). 2004 Jun;43(6):704-711.
20. Pincus T, Amara I, Segurado OG, et al. Relative effciencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol. 2008 Feb;35(2):201-205.
21. Wells G, Li T, Maxwell L, et al. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis. 2008 Feb;67(2):260-265.
22. Pincus T, Zelinger D, Bolce RJ. High/moderate versus low activity/remission patient proportions are similar according to DAS28 (disease activity score), CDAI (clinical disease activity index) and RAPID3 (routine assessment of patient index data) in ATTRACT and ASPIRE Infiximab (INFX) clinical trials in patients with rheumatoid arthritis (RA). Ann Rheum Dis. 2009;68(Suppl 3):433.
23. Pincus T, Furer V, Keystone E, et al. RAPID3 (routine assessment of patient index data) severity categories and response criteria: Similar results to DAS28 and CDAI in the RAPID1 (rheumatoid arthritis prevention of structural damage) clinical trial of certolizumab pegol (CZP). Arthritis Care Res (Hoboken). 2011 Aug;63(8):1142-1149.
24. Pincus T, Hines P, Bergman MJ, et al. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials. J Rheumatol. 2011 Dec;38(12):2565-2571.
25. Pincus T, Swearingen CJ, Bergman MJ, et al. RAPID3 on an MDHAQ is correlated significantly with activity levels of DAS28 and CDAI, but scored in 5 versus more than 90 seconds. Arthritis Care Res. 2010 Feb;62(2):181-189.
26. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984 Aug;27:864-872.
27. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol. 1991 Sep;18(9):1298-1306.
28. Callahan LF, Bloch DA, Pincus T. Identification of work disability in rheumatoid arthritis: Physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol. 1992 Feb;45(2):127-138.
29. Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients. J Rheumatol. 1998 Nov;25(11):2108-2117.
30. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol. 1999 Aug;26(8):1681-1685.
31. Lubeck DP, Spitz PW, Fries JF, et al. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum. 1986 Apr;29(4):488-493.
32. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum. 1998 Jun;41(6):107282.
33. Wolfe F, Kleinheksel SM, Cathey MA, et al. The clinical value of the Stanford health assessment questionnaire functional disability Index in patients with rheumatoid arthritis. J Rheumatol. 1988 Oct;15(10):1480-1488.
34. Leigh JP, Fries JF. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol. 1991 Sep;18(9):130712.
35. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med. 1994 Jan 1;120(1):26-34.
36. Callahan LF, Cordray DS, Wells G, Pincus T. Formal education and five-year mortality in rheumatoid arthritis: Mediation by helplessness scale scores. Arthritis Care Res. 1996 Dec;9(6):463-472.
37. Callahan LF, Pincus T, Huston JW 3rd, et al. Measures of activity and damage in rheumatoid arthritis: Depiction of changes and prediction of mortality over five years. Arthritis Care Res. 1997 Dec;10(6):381-394.
38. Söderlin MK, Nieminen P, Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol. 1998 Oct;25(10):1895-1899.
39. Sokka T, Hakkinen A, Krishnan E, Hannonen P. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis. 2004 May;63(5):494-497.
40. Hart LE, Tugwell P, Buchanan WW, et al. Grading of tenderness as a source of interrater error in the Ritchie articular index. J Rheumatol. 1985 Aug;12(4):716-717.
41. Lewis PA, O'Sullivan MM, Rumfeld WR, et al. Significant changes in Ritchie scores. Br J Rheumatol. 1988 Feb;27(1):326.
42. Klinkhoff AV, Bellamy N, Bombardier C, et al. An experiment in reducing interobserver variability of the examination for joint tenderness. J Rheumatol. 1988 Mar;15(3):492-4.
43. Thompson PW, Hart LE, Goldsmith CH, et al. Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation. J Rheumatol. 1991 May;18(5):661-5.
44. Scott DL, Choy EHS, Greeves A, et al. Standardising joint assessment in rheumatoid arthritis. Clin Rheumatol. 1996 Nov;15(6):579-582.
45. Kvien TK, Mowinckel P, Heiberg T, et al. Performance of health status measures with a pen based personal digital assistant. Ann Rheum Dis. 2005 Oct;64(10):1480-1484.
46. Sokka T, Pincus T. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov;35(4):71322, v-vi.
47. Pincus T, Askanase AD, Swearingen CJ. A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am. 2009 Nov;35(4):819-827, x.
48. Osborne RH, Wilson T, Lorig KR, McColl GJ. Does selfmanagement lead to sustainable health benefts in people with arthritis? A 2-year transition study of 452 Australians. J Rheumatol. 2007 May;34(5):1112-1117.
49. Pincus T, Skummer PT, Grisanti MT, et al. MDHAQ/RAPID3: A roadmap for all rheumatology visits when the entire MDHAQ is completed by all patients at all visits and reviewed by the doctor before the encounter. Bull NYU Hosp Jt Dis. 2012; In press.
50. Castrejón I, Yazici Y, Pincus T. Self-report RADAI joint counts on a MDHAQ are informative in a cohort of consecutive patients with rheumatic diseases other than RA seen in usual care. Arthritis Care Res (Hoboken). 2012 Jul 17. doi: 10.1002/acr.21793. [Epub ahead of print]